Pfizer Q1 FY26: where the revenue came from and where it went
The whole income statement of Pfizer for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jan 1 – Mar 29, 2026
- Reported
- May 5, 2026
Revenue$14.5B
+5% year over year
Gross profit$10.9B
75% margin
Operating profit−$3.2B
−22% margin
Net profit$2.7B
19% margin
Net profit is larger than what operations earned, because the statement adds $6.3B below it, under Other income, net.
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 14.5 | 100% | +5% |
| US | 8.7 | 60% | +4% |
| Developed markets | 3.4 | 24% | +8% |
| International emerging | 2.3 | 16% | +6% |
| Cost of revenue | −3.5 | 25% | |
| Gross profit | 10.9 | 75% margin | −4pp |
| SG&A | −3.0 | 20% | −2pp |
| Other | −11.1 | 77% | |
| Operating profit | −3.2 | −22% margin | +0pp |
| Other income, net | 6.3 | ||
| Tax | −0.5 | ||
| Net profit | 2.7 | 19% margin | −3pp |
359 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest